Status:
UNKNOWN
Voluntary Drug Poisoning by Psychoactive Molecules: Identify Cognitive Markers
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Suicide
Drug Poisoning
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
To identify in patients admitted for Voluntary drug poisoning (IMV) by psychoactive substances, T1 predictors of T2 recall of psychiatric interview and care project.
Detailed Description
The methodology will compare the episodic memory results of patients admitted for IMV who have exclusively ingested amnesic substances to a subject control group that has made IMV with non-amnesic sub...
Eligibility Criteria
Inclusion
- Group amnesic substances :
- Age from 18 to 65 years
- Admitted to emergencies for IMV by benzodiazepines
- Supported at Toulouse University Hospital (hospitalization, outpatient)
- Group control :
- Age from 18 to 65 years
- Admitted to emergencies for IMV by non-depressive substances of the central nervous system
- Supported at Toulouse University Hospital (hospitalization, outpatient)
Exclusion
- Cognitive Disorder Due to an Organic Disorder Neuro Degenerative Disease, Korsakoff Syndrome) or Mental Retardation Diagnosed
- Patient under guardianship
- Not speaking and / or not reading French
- Neurodegenerative disease diagnosed
Key Trial Info
Start Date :
January 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2019
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03481192
Start Date
January 2 2018
End Date
January 1 2019
Last Update
March 29 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Toulouse
Toulouse, France, 31059